B-Raf specific antibody responses in melanoma patients

BACKGROUND: Mutations of the BRAF gene are the most common genetic alteration in melanoma. Moreover, BRAF mutations are already present in benign nevi. Being overexpressed and mutated, B-Raf is a potential target for the immune system and as this mutation seems to be an early event, a humoral immune...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMC Cancer
Egile Nagusiak: Fensterle, Joachim, Becker, Jürgen C, Potapenko, Tamara, Heimbach, Veronika, Vetter, Claudia S, Bröcker, Eva B, Rapp, Ulf R
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMC 2004
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC518968/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15361259/
https://ncbi.nlm.nih.govhttps://doi.org/10.1186/1471-2407-4-62
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak